Dapsone myths vs facts: what the evidence actually shows

Last updated 2026-07-30

Is dapsone gel the same drug as oral dapsone?

Chemically, yes. Functionally, treat them as two different medicines with two different risk profiles. Topical dapsone (brand name Aczone, 5% and 7.5% gel) is applied to the skin for acne. Very little of it gets into the bloodstream. The FDA approved Aczone 7.5% based on trials showing it worked as well in patients with G6PD deficiency as in patients without it, because absorption through skin is low enough that hemolysis risk is minimal at that dose ^[1]. Oral dapsone is a sulfone antibiotic, originally developed for leprosy and still used for that, for dermatitis herpetiformis, and for Pneumocystis pneumonia prevention in some HIV/AIDS regimens. It's swallowed, it circulates through the whole body, and it carries real hematologic risks that the topical form mostly avoids ^[2]. The myth that causes actual harm is treating these as interchangeable, either assuming the gel is as risky as the pills, or assuming the pills are just a stronger version of the same safe acne treatment. Neither is true. If you're comparing options for acne, start with what the dapsone success rate looks like for the topical form specifically, since that's the version almost everyone means when they ask about dapsone for skin.

Does topical dapsone actually work for acne, or is that a myth?

It works, modestly, and mostly for inflammatory acne. It is not the strongest topical acne treatment available, and claims that it clears acne fast or works as well as isotretinoin are myths. The key trials for Aczone 5% gel, submitted to the FDA, showed roughly a 40 to 50% reduction in inflammatory lesion counts over 12 weeks compared to about 30% with vehicle gel alone ^[1]. A 2016 trial of Aczone 7.5% gel used once daily found similar results, with success rates (defined as "clear" or "almost clear" on a global assessment) reached by about 30% of patients at week 12, versus about 21% on vehicle ^[3]. That's a real effect, but it's not dramatic, and it's slower than people expect. Most users see visible improvement between weeks 8 and 12, not weeks 2 and 3. If you want the week-by-week picture, the dapsone results timeline breaks down what's realistic to expect and when. The myth that dapsone gel is only for women with hormonal acne isn't supported either. Subgroup data in FDA review documents show benefit across sexes, though some studies noted slightly larger effects in female patients, likely tied to acne subtype rather than the drug itself ^[1].

Do you need a G6PD test before using dapsone gel?

For the gel, no, and the FDA label says so directly. For oral dapsone, yes, always, no exceptions. G6PD (glucose-6-phosphate dehydrogenase) deficiency is a genetic condition, more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent, that leaves red blood cells vulnerable to oxidative damage. Dapsone is an oxidant drug. In G6PD-deficient people taking oral dapsone, it can trigger hemolytic anemia, sometimes severe enough to need transfusion ^[4]. The FDA-approved label for Aczone 7.5% gel states that in clinical trials, patients with G6PD deficiency who used the topical gel did not show clinically meaningful drops in hemoglobin or signs of hemolysis, and the label does not require G6PD screening before starting the topical product ^[1]. That's a genuinely reassuring, well-documented finding, not a marketing claim. Oral dapsone is a different story entirely. Every major dermatology and infectious disease reference recommends G6PD testing before starting oral dapsone, because hemolysis risk is dose-dependent and can appear within the first few weeks of treatment ^[4][5]. If you're prescribed oral dapsone for anything, a G6PD test should happen first. If your prescriber skips that step, ask why.

What are the real risks of oral dapsone, and how common are they?

Four risks matter most with oral dapsone: hemolytic anemia, methemoglobinemia, dapsone hypersensitivity syndrome, and agranulocytosis. None of these are common with the topical gel at typical acne doses. Hemolysis and methemoglobinemia happen in nearly everyone taking oral dapsone to some degree; it's dose-related and usually mild, but it can be severe in G6PD-deficient patients or at higher doses (100mg/day and above) ^[4][5]. Methemoglobinemia shows up as cyanosis (bluish skin or lips) and low pulse oximeter readings that don't respond to oxygen the way you'd expect. Dapsone hypersensitivity syndrome (sometimes grouped with DRESS, drug reaction with eosinophilia and systemic symptoms) is rarer but far more dangerous. It typically appears 2 to 6 weeks after starting oral dapsone, with fever, rash, and organ involvement (liver, most often). Reported mortality in DHS case series runs in the range of 9.9% based on pooled case reports, though exact incidence is hard to pin down because it's not systematically tracked in a national registry ^[6]. Agranulocytosis, a dangerous drop in white blood cells, is rare but is why some protocols include periodic blood count monitoring in the first three months of oral dapsone therapy ^[5]. Here's the comparison in one place: | Risk | Topical dapsone (Aczone gel) | Oral dapsone |

Is it true that dapsone gel causes skin peeling or discoloration?

Mild peeling, dryness, and a temporary orange or yellowish tint at the application site are real and documented, not a myth, but they're minor compared to what people fear. A harmless but startling reaction: if you apply benzoyl peroxide at the same time or right after dapsone gel, the combination can cause a temporary yellow-orange skin (and sometimes facial hair) discoloration. This is a cosmetic issue, not a safety issue, and it washes out. The Aczone label notes this interaction explicitly and advises separating application times if you use both ^[1]. Actual peeling and dryness are reported in trials at low rates, generally under 5% of users, and usually mild ^[3]. This is much gentler than what you'd see with topical retinoids or benzoyl peroxide alone at higher concentrations. For a fuller picture of what side effects actually look like on skin, day by day, the dapsone before and after resource shows what changes are typical versus concerning.

Does dapsone interact badly with other acne treatments?

The main documented interaction is cosmetic (the benzoyl peroxide discoloration above), not medical. Dapsone gel is commonly used alongside other topicals, including retinoids and benzoyl peroxide, in real-world dermatology practice, and combination use was part of what later 7.5% gel trials evaluated ^[3]. Oral dapsone has more meaningful drug interactions. Trimethoprim can raise dapsone blood levels and increase hemolysis and methemoglobinemia risk. Rifampin can lower dapsone levels, reducing efficacy for infections like leprosy. Anyone on oral dapsone needs their full medication list reviewed by the prescriber, more than a quick check ^[5]. This is another place where confusing the two forms causes real confusion online. Forum posts warning about "dapsone drug interactions" are almost always describing the oral drug's interaction profile, not the topical gel's, and readers researching acne treatment can end up scared off a low-risk product because of information that applies to a different drug and a different patient population.

Is dapsone gel safe during pregnancy or breastfeeding?

Neither is a settled "yes," and this is a place where honest hedging matters more than a confident answer. Aczone is a Pregnancy Category C-era product (the FDA moved away from letter categories in 2015, but Aczone's original labeling predates that change), meaning animal studies didn't show clear fetal harm at relevant doses, but there are no well-controlled human trials in pregnant women ^[1]. Most dermatologists treat it as a discuss-with-your-OB decision rather than a hard no, given the minimal systemic absorption, but that's a clinical judgment call, not a guarantee backed by human trial data. Oral dapsone is more of a known quantity in pregnancy because it's been used for decades in leprosy treatment during pregnancy, but it carries its own considerations around neonatal hemolysis and requires specialist oversight, not self-directed use ^[2]. If you're pregnant or breastfeeding and considering either form, this is a conversation for your prescriber and OB together, not a decision to make from a forum thread.

Why do some people call dapsone "outdated" or say it doesn't work as well as newer acne treatments?

Partly true, partly myth. Dapsone gel is not the first-line acne treatment most dermatologists reach for, and it's rarely used alone for moderate to severe acne. But "outdated" implies it's obsolete, and it isn't. Its niche is specific: adult women with inflammatory acne, patients who can't tolerate benzoyl peroxide or retinoids well, and people looking for an add-on rather than a monotherapy. In that niche, it performs reasonably, with the roughly 30% "clear or almost clear" rate at 12 weeks noted in the 7.5% gel trial ^[3], though topical retinoids and combination benzoyl peroxide/antibiotic products generally show comparable or better lesion reduction in head-to-head-style trial data reviewed by the American Academy of Dermatology's acne guidelines ^[7]. The honest answer: dapsone gel is a reasonable second-line or combination option, not a breakthrough, and not a waste of money either, depending on your acne type and what you've already tried. For a broader tally of where it wins and loses against alternatives, dapsone pros and cons lays out the tradeoffs without the hype.

Is dapsone only prescribed for acne, or does it treat other skin conditions too?

Both, and this is where a lot of confusion starts. Topical dapsone (Aczone) is FDA-approved specifically for acne vulgaris, in patients 9 years and older per the current label ^[1]. It is not FDA-approved for rosacea, eczema, or other rashes, though some dermatologists use it off-label for conditions like bullous pemphigoid-adjacent presentations or certain neutrophilic dermatoses in topical form, with much thinner evidence behind that use. Oral dapsone has a longer, more established list of approved and off-label uses: leprosy (Hansen's disease), dermatitis herpetiformis (the itchy, blistering rash linked to celiac disease), Pneumocystis jirovecii pneumonia prophylaxis, and off-label use in conditions like linear IgA bullous dermatosis and some vasculitis-adjacent skin diseases ^[2]. These are specialist-managed uses, generally under a dermatologist or infectious disease physician, with monitoring built in. If someone is discussing dapsone for "dermatitis," it's worth clarifying which dermatitis and which form of the drug, because dermatitis herpetiformis (oral dapsone territory) and general dermatitis or eczema (not an approved use for either form) get confused constantly in casual conversation.

What does the evidence actually say about dapsone's success rate for acne?

Trial data puts topical dapsone's "clear or almost clear" outcome at roughly 30% of patients by week 12 with the 7.5% gel, versus about 21% on vehicle gel, based on the pooled phase 3 trials submitted for FDA approval ^[3]. Lesion count reductions in the original 5% gel trials ran around 40 to 50% for inflammatory lesions over 12 weeks ^[1]. Those numbers describe averages across trial populations, not any individual's experience. Real-world results vary by acne severity, skin type, and whether dapsone is used alone or combined with something else like a retinoid. If you want the full breakdown, including how success is defined in these trials and what the honest range of outcomes looks like, dapsone success rate covers it in more depth than a single paragraph can. And for a broader gut check on whether it's worth trying given the cost and time commitment, is dapsone worth it walks through the decision directly.

How do you get topical dapsone, and does it require a prescription?

Yes, both strengths (5% and 7.5%) require a prescription in the United States; there's no over-the-counter version ^[1]. A dermatologist or other licensed prescriber needs to evaluate your acne and confirm dapsone gel is appropriate before writing it. If you're prescribed topical dapsone, Dapsone Rx works with a provider-reviewed process to connect patients with appropriate prescribing and fulfillment through a licensed pharmacy partner, rather than compounding or manufacturing anything itself. That distinction matters: any legitimate source of prescription dapsone should route through a licensed pharmacy, not a gray-market supplier. Before committing, it's worth reading real patient experiences rather than relying on marketing copy alone. Dapsone reviews collects what actual users report about timeline, side effects, and results, which tends to be a more grounded picture than any single clinical trial summary.

What should you actually watch for if you're on oral dapsone?

If you or someone you know is on oral dapsone for a condition like dermatitis herpetiformis or leprosy, the warning signs to know are: unusual fatigue or shortness of breath (possible anemia or methemoglobinemia), bluish or gray skin discoloration especially around lips and fingertips (methemoglobinemia), fever with rash starting 2 to 6 weeks after starting the drug (possible dapsone hypersensitivity syndrome), and sore throat or signs of infection (possible agranulocytosis) ^[4][5][6]. Routine monitoring for oral dapsone typically includes a G6PD test before starting, then periodic complete blood counts and liver function tests during the first few months, per standard dermatology prescribing practice referenced in clinical reviews ^[5]. This is not a drug to start and forget. If your prescriber isn't ordering baseline G6PD testing, ask directly before you take the first dose.

Frequently asked questions

Is dapsone gel the same as oral dapsone tablets?

Chemically related, functionally different. Topical dapsone (Aczone gel) is FDA-approved for acne and barely absorbs into the bloodstream. Oral dapsone is a sulfone antibiotic used for leprosy, dermatitis herpetiformis, and PCP prevention, with much higher systemic exposure and real risks like hemolysis and methemoglobinemia that the gel doesn't carry at approved acne doses.

Do I need a G6PD test before using dapsone gel for acne?

No. The FDA-approved label for Aczone 7.5% gel is based on trials showing no clinically meaningful hemolysis in G6PD-deficient patients using the topical product, so routine G6PD screening isn't required before starting the gel. G6PD testing is required before starting oral dapsone, which is a different situation entirely.

Can dapsone gel cause a hemolytic reaction like the pills do?

It's not reported as a clinically meaningful risk at approved topical doses, even in patients with G6PD deficiency, per FDA trial data. Systemic absorption from the gel is low enough that the oxidative stress that causes hemolysis with oral dapsone doesn't reach the same threshold. This is one of the clearest topical-versus-oral distinctions in the data.

Why does dapsone gel turn my skin yellow or orange?

This usually happens when dapsone gel is applied at the same time as benzoyl peroxide; the combination can cause a temporary orange-yellow tint on skin or facial hair. It's cosmetic, not dangerous, and it fades. The Aczone label recommends applying the two products at different times of day to avoid it.

Is dapsone considered an outdated acne treatment?

Not outdated, but not first-line either. Most dermatologists reach for retinoids or benzoyl peroxide combinations first. Dapsone gel fits best as a second-line option or add-on, especially for adult women with inflammatory acne or people who can't tolerate stronger topicals. Trial data shows real but modest benefit, not a breakthrough result.

What is dapsone hypersensitivity syndrome?

A rare but serious reaction to oral dapsone, appearing roughly 2 to 6 weeks after starting the drug, with fever, rash, and organ involvement, most often the liver. It's grouped with DRESS-type drug reactions. Pooled case-report data put mortality around 9.9%, though a true population incidence isn't well tracked. This risk applies to oral dapsone, not the topical gel.

Can pregnant women use dapsone gel or oral dapsone?

Neither has a simple yes or no answer. Topical dapsone's original labeling predates current FDA pregnancy categories and lacks well-controlled human trial data, though systemic absorption is low. Oral dapsone has decades of use in pregnant leprosy patients but needs specialist monitoring for neonatal hemolysis risk. Either way, this needs a direct conversation with your prescriber and OB.

What conditions is oral dapsone actually approved to treat?

Leprosy (Hansen's disease) and dermatitis herpetiformis are core FDA-recognized uses, along with off-label use for Pneumocystis pneumonia prophylaxis and some autoimmune blistering skin conditions. It is not an approved or common treatment for acne. Acne treatment with dapsone is done through the topical gel form only.

How long does it take to see results from dapsone gel for acne?

Trial data shows meaningful improvement typically building between weeks 8 and 12, not in the first two or three weeks. Aczone 7.5% gel trials reported about 30% of patients reaching 'clear or almost clear' status by week 12, compared to about 21% using vehicle gel alone. Early weeks often show little visible change.

Does dapsone gel interact with benzoyl peroxide or retinoids?

The known interaction with benzoyl peroxide is cosmetic skin discoloration, not a safety issue, and separating application times avoids it. Dapsone gel is commonly combined with retinoids or benzoyl peroxide in real dermatology practice without a documented safety interaction, unlike oral dapsone, which has real interactions with drugs like trimethoprim and rifampin.

What blood tests are needed before starting oral dapsone?

A G6PD test is standard before starting oral dapsone, since deficiency raises hemolysis risk substantially. Many prescribers also get baseline complete blood counts and liver function tests, then repeat those periodically through the first few months of treatment, since agranulocytosis and liver effects can appear early in therapy.

Is it true dapsone causes agranulocytosis in most patients?

No, this is a myth born from real but rare risk. Agranulocytosis (a dangerous drop in white blood cells) is a recognized but uncommon adverse effect of oral dapsone, which is why periodic blood count monitoring is recommended in the first few months of treatment. It is not a common outcome, and it isn't reported as a risk of the topical gel.

Sources

1. FDA, Aczone (dapsone) 7.5% Gel prescribing information: FDA approval, G6PD trial findings, benzoyl peroxide interaction, pregnancy labeling for topical dapsone
2. FDA, Dapsone Tablets USP prescribing information: Oral dapsone approved uses including leprosy and dermatitis herpetiformis
3. Del Rosso JQ, et al., Journal of Clinical and Aesthetic Dermatology, 2016 trial of dapsone 7.5% gel: 12-week success rates for Aczone 7.5% gel once daily versus vehicle
4. CDC, G6PD deficiency and drug-induced hemolysis clinical guidance: G6PD deficiency mechanism and oxidant drug risk including dapsone
5. StatPearls (NCBI Bookshelf), Dapsone toxicity and monitoring review: Methemoglobinemia, agranulocytosis, monitoring recommendations, and drug interactions for oral dapsone
6. Lorenz M, et al., dapsone hypersensitivity syndrome case series review: Onset timing and reported mortality rate of dapsone hypersensitivity syndrome
7. American Academy of Dermatology, Guidelines of care for acne vulgaris management: Comparative context on topical acne treatment options including retinoids and benzoyl peroxide combinations